Effecy and Safety of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors on Atrial Fibrillatio
Not Applicable
- Conditions
- atrial fibrillation
- Registration Number
- JPRN-UMIN000024326
- Lead Sponsor
- Hyogo collage of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1. Prior history of stroke / transient ischemic attack within 3-month 2. Valvular AF 3. Prior history of cardiac surgery 4. Chronic kidney disease (eGFR <30)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome is recurrence of atrial fibrillation at 12-month after catheter ablation.
- Secondary Outcome Measures
Name Time Method